1. Home
  2. HOUR vs LONA Comparison

HOUR vs LONA Comparison

Compare HOUR & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

N/A

Current Price

$1.81

Market Cap

61.2M

ML Signal

N/A

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$5.73

Market Cap

71.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOUR
LONA
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.2M
71.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
HOUR
LONA
Price
$1.81
$5.73
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $17.33
AVG Volume (30 Days)
19.2K
★ 455.8K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 150.00
N/A
EPS
★ 0.05
N/A
Revenue
★ $142,440,236.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.72
★ N/A
Revenue Growth
★ 3.03
N/A
52 Week Low
$1.67
$2.21
52 Week High
$3.18
$14.21

Technical Indicators

Market Signals
Indicator
HOUR
LONA
Relative Strength Index (RSI) 45.84 49.07
Support Level $1.74 $4.55
Resistance Level $2.05 $6.13
Average True Range (ATR) 0.11 1.01
MACD -0.00 0.21
Stochastic Oscillator 21.87 77.86

Price Performance

Historical Comparison
HOUR
LONA

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: